Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Biochemical Pharmacology
|
September 18, 2002
SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells
Bo Yu, Maureen E Lane, Scott Wadler
Seminars in Respiratory and Critical Care Medicine
|
July 25, 2008
Lung biopsy: special techniques
Matthew D Cham, Maureen E Lane, Claudia I Henschke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies
Della Makower, Alla Rozenblit, Howard Kaufman, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]
|
March 28, 2003
Clinical applications of p53-directed gene therapy
Scott Wadler, Della Makower, Bo Yu, et al.
Annals of Clinical and Translational Neurology
|
December 11, 2014
Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patients
Gigi J Ebenezer, Karen Carlson, Diana Donovan, et al.
Cancer Chemotherapy and Pharmacology
|
October 29, 2010
Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer
Allyson J Ocean, Paul Christos, Joseph A Sparano, et al.
BMC Cancer
|
April 18, 2015
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity
Sasha E Stanton, Maureen M Ward, Paul Christos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 30, 2013
Overcoming the response plateau in multiple myeloma: a novel bortezomib-based strategy for secondary induction and high-yield CD34+ stem cell mobilization
Ruben Niesvizky, Tomer M Mark, Maureen Ward, et al.
Breast Cancer Research and Treatment
|
December 14, 2011
Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients
Sarika Jain, Maureen M Ward, Jennifer O'Loughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer
Nasser Altorki, Maureen E Lane, Thomas Bauer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Biochemical Pharmacology
|
September 18, 2002
SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells
Bo Yu, Maureen E Lane, Scott Wadler
Seminars in Respiratory and Critical Care Medicine
|
July 25, 2008
Lung biopsy: special techniques
Matthew D Cham, Maureen E Lane, Claudia I Henschke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies
Della Makower, Alla Rozenblit, Howard Kaufman, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]
|
March 28, 2003
Clinical applications of p53-directed gene therapy
Scott Wadler, Della Makower, Bo Yu, et al.
Annals of Clinical and Translational Neurology
|
December 11, 2014
Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patients
Gigi J Ebenezer, Karen Carlson, Diana Donovan, et al.
Cancer Chemotherapy and Pharmacology
|
October 29, 2010
Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer
Allyson J Ocean, Paul Christos, Joseph A Sparano, et al.
BMC Cancer
|
April 18, 2015
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity
Sasha E Stanton, Maureen M Ward, Paul Christos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 30, 2013
Overcoming the response plateau in multiple myeloma: a novel bortezomib-based strategy for secondary induction and high-yield CD34+ stem cell mobilization
Ruben Niesvizky, Tomer M Mark, Maureen Ward, et al.
Breast Cancer Research and Treatment
|
December 14, 2011
Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients
Sarika Jain, Maureen M Ward, Jennifer O'Loughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer
Nasser Altorki, Maureen E Lane, Thomas Bauer, et al.
Page
of 2